Vivoryon Therapeutics (previously known as Probiodrug) is a precision intervention company specializing in discovering and developing therapies for patients suffering from age-related diseases. It has a pipeline of product candidates across various stages of development, currently focused on Alzheimer’s disease and cancer immune checkpoint inhibition.